Skip to main content

Corteva Inc

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

CTVA$12.11+1.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Revenue

NOTE 4 -REVENUE

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $131 million, $134 million and $126 million at March 31, 2024, December 31, 2023 and March 31, 2023, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period ofone year tosix years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesMarch 31, 2024December 31, 2023March 31, 2023
(In millions)
Accounts and notes receivable - trade1$6,760$4,329$7,334
Contract assets - current2282726
Contract assets - noncurrent3676763
Deferred revenue - current2,6943,4062,712
Deferred revenue - noncurrent4104108103
  1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.

  2. Included in other current assets in the interim Consolidated Balance Sheets.

  3. Included in other assets in the interim Consolidated Balance Sheets.

  4. Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the three months ended March 31, 2024 and 2023 from amounts included in deferred revenue at the beginning of the period was $1,205 million and $1,201 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:

Three Months Ended March 31,
(In millions)20242023
Corn$2,087$1,979
Soybean292269
Other oilseeds245301
Other127146
Seed2,7512,695
Herbicides8861,242
Insecticides373409
Fungicides295359
Other187179
Crop Protection1,7412,189
Total$4,492$4,884

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:

SeedThree Months Ended March 31,
(In millions)20242023
North America1$1,471$1,323
EMEA29181,012
Latin America271259
Asia Pacific91101
Total$2,751$2,695
Crop ProtectionThree Months Ended March 31,
(In millions)20242023
North America1$616$879
EMEA2670801
Latin America244293
Asia Pacific211216
Total$1,741$2,189
  1. Represents U.S. & Canada.

  2. Europe, Middle East and Africa ("EMEA").

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.